This study is aimed to depict the epidemiological trend, aetiologies, clinical characteristics, treatment options of IS-NOAC in face of the rapidly increasing NOAC usage. Knowledge on this ischaemic stroke entity will define clinical characteristics, identify preventable causes and inform resource allocation on the evaluation modalities, reperfusion strategies and forecast future burden of IS-NOAC.
Data will be retrieved from the stroke registry of Prince of Wales Hospital which recorded all in- and out-patients with stroke or transient ischaemic attack (TIA). All consecutive adult patients with known AF who developed ischaemic stroke or TIA in 2010, 2012, 2014, 2016 and 2018 (i.e. 5 full yearly time-points) and categorize the patients according to their anticoagulation status (elaborated below) with the inclusion and exclusion criteria stated will be recruited. All demographic data, blood results, imaging and assessment data will be retrieved from electronic patient record (CMS system) and stroke registry. All-cause mortality at 1 year will be verified via CMS system too.
Study Type
OBSERVATIONAL
Enrollment
870
Chinese University of Hong Kong
Hong Kong, Hong Kong
RECRUITINGCompliance affects the outcomes of ischemic stroke during NOAC usage.
To depict epidemiological trend and aetiologies on different dosage of NOAC in stroke patients.
Time frame: 30 Sept 2021
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.